OTC · BRRGF
BerGenBio ASA
$97.09$0.00 (0.0%)
BerGenBio ASA’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · AWKNF · USD
Stock price, earnings
Quote as of May 27, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Awakn Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 51.27% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Awakn Life Sciences Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -$0.08-83.31% vs estimate |
| $353.37K-15.54% vs estimate |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$97.09$0.00 (0.0%)
BerGenBio ASA’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.04$0.00 (0.0%)
Revitalist Lifestyle and Wellness Ltd.: Healthcare · Medical - Care Facilities.
$0.04$0.00 (0.0%)
Field Trip Health & Wellness Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.76% below the high.
$0.00$0.00 (0.0%)
Oxford Cannabinoid Technologies Holdings Plc’s quoted price sits in the lower half of its reported 52-week range, 93.32% below the high.
$0.01-$0.00 (-1.95%)
Delta 9 Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.33% below the high.
$0.68$0.00 (0.0%)
ATI Physical Therapy, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.6% below the high.
$0.08$0.00 (0.0%)
Eve & Co Incorporated’s quoted price sits in the lower half of its reported 52-week range, 36.31% below the high.
$0.00+$0.00 (+45.0%)
GABY Inc.: Healthcare · Medical - Pharmaceuticals.
